Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency
Wenyu Zhang(The University of Tokyo), Susumu Goyama(Cincinnati Children's Hospital Medical Center)
Cited by 3
Related Papers
SIRT1 modulates cell cycle progression by regulating CHK2 acetylation−phosphorylation
|Cell Death and Differentiation|2019|85
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO
|Leukemia|2015|65
ASXL1 and SETBP1 mutations promote leukaemogenesis by repressing TGFβ pathway genes through histone deacetylation
|Scientific Reports|2018|36
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia
|Communications Biology|2023|16